Bravecto Vs Simparica
Bravecto and Simparica are both popular brands of oral flea and tick medications for dogs. Both products are designed to protect dogs from infestations of fleas and ticks, and they are often prescribed to provide long-lasting protection. Let's compare some key aspects of Bravecto and Simparica:
Active Ingredients:
Bravecto: The active ingredient in Bravecto is fluralaner, which belongs to the isoxazoline class of drugs.
Simparica: The active ingredient in Simparica is sarolaner, also from the isoxazoline class.
Duration of Action:
Bravecto: It provides protection against fleas and ticks for up to 12 weeks (3 months) with a single dose.
Simparica: It provides protection against fleas and ticks for up to 4-5 weeks with a single dose.
Spectrum of Activity: Both medications are effective against fleas and various species of ticks, including the American dog tick, the black-legged tick (deer tick), and the lone star tick.
Administration:
Bravecto: It comes in chewable tablet form and is given orally.
Simparica: It also comes in chewable tablet form and
is administered orally.
Safety: Both Bravecto and Simparica have been generally well-tolerated by dogs. However, as with any medication, there is a small risk of side effects. Common side effects may include vomiting, diarrhea, and lethargy. It's essential to discuss any potential risks with your veterinarian, especially if your dog has a history of sensitivities or allergies.
Use in Different Dog Sizes: Both Bravecto and Simparica are available in different formulations to suit various dog sizes and weights.
When choosing between Bravecto and Simparica, it's important to consider the specific needs of your dog, your veterinarian's recommendation, and the prevalence of fleas and ticks in your area. It's always best to consult with your veterinarian before starting any flea and tick prevention treatment to ensure it's the right fit for your pet and to discuss any potential contraindications based on their medical history.
To order check out the site listed below!
Comments